IDX
vs
S&P/ASX 300

Over the past 5 years, IDX has underperformed S&P/ASX 300, delivering a return of -16% compared to the S&P/ASX 300's 22% growth.

Stocks Performance
IDX vs S&P/ASX 300

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Performance Gap
IDX vs S&P/ASX 300

Performance Comparison
IDX vs S&P/ASX 300

1 Month 3 Months 6 Months 1 Year 5 Years 10 Years 20 Years
IDX
Integral Diagnostics Ltd
2%
-4%
11%
51%
-16%
103%
103%
S&P/ASX 300
Market Index
-3%
-1%
6%
7%
22%
51%
99%

Integral Diagnostics Ltd
Glance View

Market Cap
680.7m AUD
Industry
Health Care

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.

IDX Intrinsic Value
8.34 AUD
Undervaluation 65%
Intrinsic Value
Price

See Also

Back to Top